TCTR20211129002
Recruiting
Not Applicable
Incidence of parasitic infection in patients with hypereosinophilia
Siriraj Hospital Mahidol University0 sites120 target enrollmentNovember 29, 2021
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- The patient 18 years and older who were diagnosed with more eosinophils 1,500/cu.mm.
- Sponsor
- Siriraj Hospital Mahidol University
- Enrollment
- 120
- Status
- Recruiting
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\.The patients diagnosed with more eosinophils 1,500/cu.mm., all new who sent to consult hematologist before undergoing further testing to determine the cause.
- •2\.The patient 18 years and older.
- •3\.The patients participate project by sign ICF
Exclusion Criteria
- •Patients who refused to participate in the research project.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Not Applicable
Parasites and risk factors for heart attack and stroke in rural and urban areas of GaboISRCTN12708965European & Developing Countries Clinical Trials Partnership408
Completed
Not Applicable
Investigation of incidence of infections in patients with IBDlcerative colitis, Crohn's disease, Indeterminate colitisJPRN-UMIN000005445Gastroenterology and Hepatology, Tokyo Medical and Dental University200
Completed
Phase 4
King's invasive aspergillosis study II (KIASII)Specialty: Haematology, Primary sub-specialty: HaematologyUKCRC code/ Disease: Infection/ Other bacterial diseasesInfections and InfestationsInvasive fungal diseaseISRCTN11847553King's College Hospital NHS Foundation Trust120
Active, not recruiting
Phase 1
Incidence of Invasive Fungal Disease in Patients receiving Immunosuppressive Therapy, Intensive Chemotherapy or Reduced Intensity Haematopoietic Stem Cell Transplantation on Posaconazole tablet ProphylaxisAplastic Anaemia, Myelodysplastic syndromes, Acute Myeloid Leukaemia undergoing immunosuppression therapy, high dose chemotherapy or reduced intensity stem cell transplantationMedDRA version: 19.0Level: LLTClassification code 10038271Term: Refractory anaemia with excess blasts in transformationSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 19.0Level: LLTClassification code 10059041Term: Allogeneic peripheral haematopoietic stem cell transplantSystem Organ Class: 10042613 - Surgical and medical proceduresMedDRA version: 19.0Level: LLTClassification code 10067862Term: Allogeneic stem cell transplantationSystem Organ Class: 10042613 - Surgical and medical proceduresMedDRA version: 19.0Level: PTClassification code 10038270Term: Refractory anaemia with an excess of blastsSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 19.0Level: LLTClassification code 10010776Term: Constitutional aplastic anaemiaSystem Organ Class: 10005329 - Blood and lymphatic system disordersMedDRA version: 19.0Level: LLTClassification code 10068063Term: Aplastic anaemia relapseSystem Organ Class: 10005329 - Blood and lymphatic system disordersMedDRA version: 19.0Level: LLTClassification code 10036699Term: Primary idiopathic aplastic anaemiaSystem Organ Class: 10005329 - Blood and lymphatic system disordersMedDRA version: 19.0Level: PTClassification code 10000880Term: Acute myeloid leukaemiaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 19.0Level: PTClassification code 10001756Term: Allogenic bone marrow transplantation therapySystem Organ Class: 10042613 - Surgical and medical proceduresMedDRA version: 19.0Level: LLTClassification code 10000884Term: Acute myeloid leukaemia NOSSystem Organ Class: 10029104 -Therapeutic area: Diseases [C] - Blood and lymphatic diseases [C15]EUCTR2016-001223-31-GBKing's College Hospital NHS Foundation Trust150
Recruiting
Not Applicable
Impact of antifungal prophylaxis. A prospective, multicenter, observational study in India (MISFIC)CTRI/2014/04/004544MSD PHARMA200